Childhood cancers trials in Sweden

In Sweden 65 Also abroad 2459

65 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Where
Gothenburg, Lund, Stockholm, Uppsala
Age
12 years and over
People
355 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00
Phase 1/2Taking people
CAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study)
Where
Huddinge, Uppsala
Age
18 years and over
People
18
Run by
Uppsala University
See details and how to joinNCT06002659 · EU 2024-511844-18-00
Phase 2/3Taking people
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
Where
Solna
Age
12 years and over
People
340 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07570173 · EU 2025-522267-15-00
Phase 2Taking people
177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma
Where
Solna
Age
18 months to 64 years
People
24 worldwide
Run by
Jakob Stenman
See details and how to joinNCT04903899 · EU 2023-503684-42-00
Phase 2/3Taking people
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Where
Goteborg, Huddinge, Lund
People
1,541 worldwide
Run by
Celgene
See details and how to joinNCT03435796 · EU 2023-504201-36-00
Phase 1/2Taking people
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Where
Gothenburg
Age
6 months to 25 years
People
90 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00
Phase 1/2Taking people
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Where
Gothenburg
Age
1 month to 17 years
People
134 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07630974 · EU 2025-522339-32-00
No phaseTaking people
Met Non Small Cell Cancer Registry (MOMENT)
Where
Linköping
People
700 worldwide
Run by
EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT05376891
Phase 3Taking people
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Where
Gothenburg, Linkoping, Lund, Solna, Umea, Uppsala
Age
1 year to 64 years
People
750 worldwide
Run by
Charite University, Berlin, Germany
See details and how to joinNCT07476729 · EU 2023-509392-17-00
Phase 3Taking people
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
Where
Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
Age
4 years and over
People
530 worldwide
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07871864
Phase 3Taking people
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
Where
Gothenburg, Linkoping, Lund, Stockholm, Umea, Uppsala
Age
Up to 17 years
People
137 worldwide
Run by
GPOH gGmbH
See details and how to join2022-501454-11-00 · EU 2022-501454-11-00
Phase 3Taking people
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
Where
Solna
Age
6 months and over
People
433 worldwide
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT05476939 · EU 2023-506027-29-00
Phase 3Taking people
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
Where
Goteborg, Gothenburg, Linkoping, Lund, Solna, Stockholm, Umea, Uppsala
Age
Up to 64 years
People
1,351 worldwide
Run by
GPOH gGmbH
See details and how to join2022-501180-40-00 · EU 2022-501180-40-00
Phase 3Taking people
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Where
Gothenburg, Linkoping, Lund, Stockholm, Umeå, Uppsala
Age
1 day to 1 year
People
160 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00
No phaseTaking people
Implementation of Teledermoscopy and Artificial Intelligence
Where
Lund
Age
15 years and over
People
8,000
Run by
Region Skane
See details and how to joinNCT05033678
Phase 2Taking people
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Where
Gothenburg, Huddinge, Linkoping, Lund, Umea, Uppsala
Age
Up to 19 years
People
232 worldwide
Run by
Medical University of Vienna
See details and how to joinNCT01356290 · EU 2024-515626-92-00
Phase 1/2Taking people
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Where
Stockholm
Age
1 year to 17 years
People
70 worldwide
Run by
Incyte Biosciences International Sàrl
See details and how to joinNCT03934372 · EU 2023-509699-41-00
Phase 2/3Taking people
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Where
Gavle, Solna
Age
18 years and over
People
740 worldwide
Run by
Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00
Phase 1/2Taking people
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Where
Gothenburg
Age
1 month to 17 years
People
50 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06941272 · EU 2024-518771-66-00
No phaseTaking people
Molecular and Clinical Studies of Bone and Soft Tissue Tumors
Where
Stockholm
People
50,000
Run by
Karolinska Institutet
See details and how to joinNCT07822204
Phase 2Taking people
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Where
Gothenburg, Lund, Solna
Age
1 year to 17 years
People
100 worldwide
Run by
Pfizer
See details and how to joinNCT05748171 · EU 2023-509810-13-00
Phase 3Taking people
CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML)
Where
Gothenburg, Linkoping, Lund, Solna, Umea, Uppsala
Age
Up to 64 years
People
675 worldwide
Run by
Prinses Maxima Centrum voor Kinderoncologie B.V.
See details and how to join2023-504999-25-00 · EU 2023-504999-25-00
No phaseTaking people
Siblings to a Child With Cancer: Needs and Pre-loss Grief
Where
Stockholm
Age
12 years to 24 years
People
200
Run by
Ersta Sköndal University College
See details and how to joinNCT06854822
Phase 3Taking people
An international trial for children with atypical teratoid/rhabdoid tumours (ATRT)
Where
Gothenburg, Linkoping, Lund, Stockholm, Umea, Uppsala
Age
Up to 17 years
People
301 worldwide
Run by
GPOH gGmbH
See details and how to join2022-501456-28-00 · EU 2022-501456-28-00
Phase 1/2Taking people
Phase I/II combination umbrella trial in progressive/relapsed/refractory pediatric low-grade glioma (pLGG) (EPILOGUE)
Where
Solna
Age
Up to 64 years
People
34 worldwide
Run by
Universitaetsklinikum Heidelberg AöR
See details and how to join2024-516896-34-00 · EU 2024-516896-34-00